Development

Articles

The investment will expand and upgrade manufacturing capacity and technology for pre-fillable syringes and will also includes a new manufacturing facility in Europe. 

BD to Invest $1.2 Billion Over Four Years in Pre-Fillable Syringe Manufacturing Capacity 

Feliza Mirasol is the science editor for 

Fill/finish inspection for vaccine vials and syringes must remain GMP-compliant while aiming for fast, efficient methods.

Reconfiguring Fill/Finish Inspection to Meet COVID-19 Vaccine Goals

The new facility in Grand Rapids, MI, is part of the CDMO’s aggressive expansion plan.

Grand River Aseptic Manufacturing Opens Large-Scale Injectable Fill/Finish Facility

Agnes Shanley is senior editor of Pharmaceutical Technology.

Manufacturers and the US government are investing heavily in traditional and non-traditional forms and materials to ensure supplies of containers and delivery devices for COVID-19 treatments and vaccines. 


COVID-19: Shoring Up the Drug Delivery Infrastructure

The facility will produce parenteral products and delivery devices and is set to create 460 new jobs.

Eli Lilly to Invest $470 Million into New Pharma Manufacturing Facility

As biologic drugs grow increasingly complex, drug delivery mechanisms such as prefilled syringes are being adapted to meet the challenges.

Innovations in Prefilled Syringes for Biologic Drugs

Biosimilars and biobetters have their own unique manufacturing strategies and challenges.

Biosimilars and Biobetters Strategies and Challenges

Sensors and devices being developed by nGageIT Digital Health Solutions can track patient use of oral solid-dosage or injectable drugs. 

Sensor Technology Aims to Improve Medication Adherence

Conducting stability testing on APIs/finished drug product helps ensure shelf-life storage.

Stability Testing Ensures Proper Packaging for Drug Storage

ADC Bio experts warn of impending problems in the ADC pipeline with millions wasted in development costs.

Formulation and Drug Delivery, Parenterals